These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3122431)

  • 1. [Extremely high serum transcortin levels in patients with acute B and T-cell-type lymphatic leukemia and extremely low transcortin levels in patients with multiple myeloma and an excess of light lambda chains].
    De Moor P; Boogaerts M; Faict D; Louwagie A
    Verh K Acad Geneeskd Belg; 1987; 49(5):371-91. PubMed ID: 3122431
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of aberrant transcortin levels with HLA antigens of the B and C loci: high transcortin levels are frequently found in patients with lymphatic leukemia, hairy cell leukemia, or non-Hodgkin lymphoma.
    De Moor P; Louwagie A
    J Clin Endocrinol Metab; 1980 Oct; 51(4):868-72. PubMed ID: 6932403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the humoral immune response: from immunoglobulin genes to regulatory T cell networks.
    Waldmann TA; Korsmeyer SJ; Hieter PA; Ravetch JV; Broder S; Leder P
    Fed Proc; 1983 May; 42(8):2498-503. PubMed ID: 6404657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigen CW3 combined with unexplained high transcortin levels is found in patients with acute lymphoblastic leukemia but not in their parents, sibs and offspring.
    de Moor P; Louwagie A
    J Steroid Biochem; 1986 Oct; 25(4):489-90. PubMed ID: 3464809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subgroup of all patients delimitated by two inherited factors.
    De Moor P; Boogaerts M
    Leukemia; 1987 Jul; 1(7):572. PubMed ID: 3478542
    [No Abstract]   [Full Text] [Related]  

  • 6. Steroid-carrier proteins in patients with multiple myeloma.
    De Moor P; Louwagie A; Faict D; Vanham G
    J Steroid Biochem; 1986 Aug; 25(2):261-4. PubMed ID: 3747525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do members of Li-Fraumeni families always carry an HLA antigen Cw3 together with unexplained high transcortin levels.
    De Moor P; Boogaerts M
    Br J Haematol; 1988 Jun; 69(2):290-1. PubMed ID: 3164633
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.
    Gallart T; Bladé J; Martínez-Quesada J; Sierra J; Rozman C; Vives J
    Immunology; 1985 May; 55(1):45-57. PubMed ID: 3922877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More familial leukaemia in ALL patients with both unexplained high transcortin levels and an HLA antigen Cw3.
    De Moor P; Boogaerts M; Louwagie A
    Br J Haematol; 1988 Jun; 69(2):225-7. PubMed ID: 3164632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukemia with Burkitt's lymphoma cells: membrane markers and serum immunoglobulin.
    Preud'homme JL; Brouet JC; Danon F; Flandrin G; Schaison G
    J Natl Cancer Inst; 1981 Feb; 66(2):261-4. PubMed ID: 6779044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute "high risk" and "low risk" juvenile lymphatic leukemia (proceedings)].
    Imbach P; Berchtold W; Feldges A; Laug W; Morell A; Wyss M; Wagner HP
    Schweiz Med Wochenschr; 1978 Oct; 108(41):1606. PubMed ID: 308695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
    Tosato F; Fossaluzza V; Sala P; Tonutti E
    Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring myeloma: light chain isotype suppression. A new parameter.
    Wearne A; Joshua DE; Kronenberg H
    Aust N Z J Med; 1985 Oct; 15(5):629-33. PubMed ID: 3937514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum transcortin levels, HL-A antigens and susceptibility to certain diseases].
    De Moor P; Louwagie A
    Verh K Acad Geneeskd Belg; 1980; 42(2):75-90. PubMed ID: 7223052
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of the human T cell lymphoma virus in B cell lines established from patients with adult T cell leukemia.
    Mann DL; Clark J; Clarke M; Reitz M; Popovic M; Franchini G; Trainor CD; Strong DM; Blattner WA; Gallo RC
    J Clin Invest; 1984 Jul; 74(1):56-62. PubMed ID: 6330177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin isotypes on monoclonal blood lymphocytes in human plasma cell myeloma.
    Pettersson D; Mellstedt H; Holm G
    J Clin Lab Immunol; 1980 Mar; 3(2):93-8. PubMed ID: 6782249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional behaviour and immunological phenotype of circulating B lymphocytes in multiple myeloma. Studies with pokeweed mitogen.
    Gobbi M; Caligaris-Cappio F; Campana D; Tazzari PL; Bergui L; Cavo M; Tura S
    Clin Exp Immunol; 1984 Dec; 58(3):625-30. PubMed ID: 6439450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of acute lymphocytic leukemia with B-cell phenotype and with IgM/lambda cold agglutinin production].
    Ohnishi M; Koike T; Nagai K; Aoki S; Hirosawa H; Moriyama Y; Shinada S; Shibata A
    Rinsho Ketsueki; 1985 Oct; 26(10):1659-64. PubMed ID: 3937918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.